« Back
Home /
Itepekimab Biosimilar（Anti-IL-33 Reference Antibody）

Itepekimab Biosimilar（Anti-IL-33 Reference Antibody）

Item no.	DCC-A258-100mg
Manufacturer	DCChemicals
CASRN	2226742-52-3
Amount	100 mg
Specific against	other
Available
Manufacturer - Applications	Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 6/26/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Recommend by mail